BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15810751)

  • 1. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis.
    Allen S; Raut S; Woollard J; Vassallo M
    Palliat Med; 2005 Mar; 19(2):128-30. PubMed ID: 15810751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease - a randomised placebo-controlled trial.
    Kronborg-White S; Andersen CU; Kohberg C; Hilberg O; Bendstrup E
    Respir Res; 2020 Jul; 21(1):195. PubMed ID: 32703194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
    Smallwood N; Le B; Currow D; Irving L; Philip J
    Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.
    Oxberry SG; Bland JM; Clark AL; Cleland JG; Johnson MJ
    J Palliat Med; 2013 Mar; 16(3):250-5. PubMed ID: 23368980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
    Gamborg H; Riis J; Christrup L; Krantz T
    J Opioid Manag; 2013; 9(4):269-74. PubMed ID: 24353020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
    Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
    J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulized opioids in the treatment of dyspnea.
    Quelch PC; Faulkner DE; Yun JW
    J Palliat Care; 1997; 13(3):48-52. PubMed ID: 9354041
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.
    Currow DC; McDonald C; Oaten S; Kenny B; Allcroft P; Frith P; Briffa M; Johnson MJ; Abernethy AP
    J Pain Symptom Manage; 2011 Sep; 42(3):388-99. PubMed ID: 21458217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome.
    Eiser N; Denman WT; West C; Luce P
    Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
    Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
    J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
    Currow DC; Quinn S; Ekstrom M; Kaasa S; Johnson MJ; Somogyi AA; Klepstad P
    BMJ Open; 2015 May; 5(5):e006818. PubMed ID: 25948405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids for breathlessness: a narrative review.
    Johnson MJ; Currow DC
    BMJ Support Palliat Care; 2020 Sep; 10(3):287-295. PubMed ID: 32620683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series.
    Gauna AA; Kang SK; Triano ML; Swatko ER; Vanston VJ
    J Palliat Med; 2008 May; 11(4):643-8. PubMed ID: 18454622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer.
    Boyd KJ; Kelly M
    Palliat Med; 1997 Jul; 11(4):277-81. PubMed ID: 9373578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulized morphine in the palliation of dyspnoea.
    Zeppetella G
    Palliat Med; 1997 Jul; 11(4):267-75. PubMed ID: 9373577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study.
    Johnson MJ; McDonagh TA; Harkness A; McKay SE; Dargie HJ
    Eur J Heart Fail; 2002 Dec; 4(6):753-6. PubMed ID: 12453546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial.
    Mazzocato C; Buclin T; Rapin CH
    Ann Oncol; 1999 Dec; 10(12):1511-4. PubMed ID: 10643545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dyspnea, respiratory mechanics and gas exchange in patients with idiopathic pulmonary fibrosis].
    Wesołowski S; Meleniewska-Maciszewska A; Korzeniewska-Koseła M; Kuś J; Radwan L
    Pneumonol Alergol Pol; 1997; 65(3-4):220-4. PubMed ID: 9489418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
    Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
    Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.